395 related articles for article (PubMed ID: 6091867)
1. Increased 5-phospho-alpha-D-ribose-1-diphosphate synthetase (ribosephosphate pyrophosphokinase, EC 2.7.6.1) activity in rat hepatomas.
Baló-Banga JM; Weber G
Cancer Res; 1984 Nov; 44(11):5004-9. PubMed ID: 6091867
[TBL] [Abstract][Full Text] [Related]
2. Proliferation-linked increase in phosphoribosylformylglycinamidine synthetase activity (EC 6.3.5.3).
Elliott WL; Weber G
Cancer Res; 1984 Jun; 44(6):2430-4. PubMed ID: 6722784
[TBL] [Abstract][Full Text] [Related]
3. 1-Phosphatidylinositol 4-kinase: an enzyme linked with proliferation and malignancy.
Rizzo MT; Weber G
Cancer Res; 1994 May; 54(10):2611-4. PubMed ID: 8168087
[TBL] [Abstract][Full Text] [Related]
4. 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation- and malignancy-linked signal transduction enzyme.
Singhal RL; Prajda N; Yeh YA; Weber G
Cancer Res; 1994 Nov; 54(21):5574-8. PubMed ID: 7923199
[TBL] [Abstract][Full Text] [Related]
5. Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver.
Heinrich PC; Morris HP; Weber G
Cancer Res; 1976 Sep; 36(9 pt.1):3189-97. PubMed ID: 10080
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2).
Prajda N; Morris HP; Weber G
Cancer Res; 1976 Dec; 36(12):4639-46. PubMed ID: 187329
[TBL] [Abstract][Full Text] [Related]
7. Increased uridine kinase (ATP: uridine 5'-phosphotransferase; EC 2.7.1.48) activity in human and rat tumors.
Shen F; Look KY; Yeh YA; Weber G
Cancer Biochem Biophys; 1998 Jun; 16(1-2):1-15. PubMed ID: 9923963
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase C (EC 3.1.4.11): a malignancy linked signal transduction enzyme.
Yang H; Shen F; Herenyiova M; Weber G
Anticancer Res; 1998; 18(3A):1399-404. PubMed ID: 9673347
[TBL] [Abstract][Full Text] [Related]
9. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
[TBL] [Abstract][Full Text] [Related]
10. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
Becker MA; Losman MJ; Itkin P; Simkin PA
J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
[TBL] [Abstract][Full Text] [Related]
11. Increased carbamoyl-phosphate synthetase II concentration in rat hepatomas: immunological evidence.
Reardon MA; Weber G
Cancer Res; 1985 Sep; 45(9):4412-5. PubMed ID: 4028025
[TBL] [Abstract][Full Text] [Related]
12. Decreased erythrocyte phosphoribosylpyrophosphate synthetase activity and impaired formation in thalassemia minor: a mechanism for decreased adenine nucleotide content.
Zerez CR; Lachant NA; Tanaka KR
J Lab Clin Med; 1989 Jul; 114(1):43-50. PubMed ID: 2544652
[TBL] [Abstract][Full Text] [Related]
13. Increased PRPP synthetase activity in cultured rat hepatoma cells containing mutations in the hypoxanthine-guanine phosphoribosyltransferase gene.
Graf LH; McRoberts JA; Harrison TM; Martin DW
J Cell Physiol; 1976 Jul; 88(3):331-42. PubMed ID: 178676
[TBL] [Abstract][Full Text] [Related]
14. [A modified method for phosphoribosyl pyrophosphate synthesis].
Filippova VN; Filanovskaya LI; Blinov MN
Vopr Med Khim; 1975; 21(6):663-5. PubMed ID: 175573
[TBL] [Abstract][Full Text] [Related]
15. Purine biosynthesis de novo in bovine retina: purification and characterization of amidophosphoribosyl transferase and phosphoribosyl pyrophosphate synthetase.
Kian IA; Etingof RN
Biochemistry (Mosc); 1999 Jun; 64(6):648-51. PubMed ID: 10395979
[TBL] [Abstract][Full Text] [Related]
16. Carbamyl phosphate synthetases in rat liver neoplasms.
Lawson D; Paik WK; Morris HP; Weinhouse S
Cancer Res; 1975 Jan; 35(1):156-63. PubMed ID: 162860
[TBL] [Abstract][Full Text] [Related]
17. [Purine metabolism: determination of PRPP-amidotransferase and PRPP-synthetase in lymphocytes from patients with chronic lymphatic leukemia (CLL)].
Tabucchi A; Terzuoli L; Di Stefano A; Pizzichini M; Leoncini R; Dispensa E; Marinello E
Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1097-103. PubMed ID: 2560926
[TBL] [Abstract][Full Text] [Related]
18. Decreased concentration of xanthine dehydrogenase (EC 1.1.1.204) in rat hepatomas.
Ikegami T; Natsumeda Y; Weber G
Cancer Res; 1986 Aug; 46(8):3838-41. PubMed ID: 3460692
[TBL] [Abstract][Full Text] [Related]
19. [Phosphoribosylpyrophosphate synthetase anomalies in 2 cases of gout beginning at an early age].
Lejeune E; Bouvier M; Mousson B; Llorca G; Baltassat P
Rev Rhum Mal Osteoartic; 1979; 46(7-9):457-65. PubMed ID: 228383
[TBL] [Abstract][Full Text] [Related]
20. Human phosphoribosylpyrophosphate synthetase: radioimmunochemical quantitation in erythrocytes and fibroblasts.
Itkin P; Woo S; Becker MA
J Lab Clin Med; 1984 Jul; 104(1):96-109. PubMed ID: 6330252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
